Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease
Alex E. Roher(Barrow Neurological Institute), Thomas G. Beach(Banner Health), J Anthony(Midwestern University), Lucia I. Sue(Banner Sun Health Research Institute), Nicole Weiss(Midwestern University), Yu‐Min Kuo(National Cheng Kung University), Douglas G. Walker(Banner Sun Health Research Institute), Dean C. Luehrs(Banner Sun Health Research Institute), Walter M. Kalback(Banner Sun Health Research Institute), Tyler A. Kokjohn(Midwestern University), Desiree Watson(Midwestern University), Mark R. Emmerling, Warren J. Goux(Midwestern University)
Cited by 281
Related Papers
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k